Ménétrier’s Disease of the Stomach: A Clinical Challenge

  • Nils W. G. LambrechtEmail author
Stomach and Duodenum (Joseph R. Pisegna, Section Editor)


Ménétrier’s disease is a rare hyperproliferative protein-losing gastropathy of the gastric foveolar epithelium. Most common symptoms include epigastric pain with fullness and vomiting, and generalized peripheral edema with hypoalbuminemia. Radiologically, the wall of the gastric body and fundus is diffusely thickened, often with antral sparing. Giant rugal edematous folds are seen on gastroscopy, and histology of biopsy material shows diffuse foveolar hyperplasia with cystic dilatation of the glandular portion of the gastric mucosa in the absence of significant inflammatory infiltrate. The recent discovery of transforming growth factor α overexpression opens the way of epidermal growth factor receptor blockade with cetuximab as first-line treatment modality in severe cases of Ménétrier’s disease.


Ménétrier’s disease Hyperproliferative protein-losing gastropathy Stomach TGFα EGFR Cetuximab 



No potential conflicts of interest relevant to this article were reported.


Papers of particular interest, published recently, have been highlighted as: •Of importance

  1. 1.
    Bayerdorffer E, Ritter MM, Hatz R, et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori–is Helicobacter pylori a pathogenic factor in Menetrier’s disease? Gut. 1994;35:701–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Beauchamp RD, Barnard JA, McCutchen CM, et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest. 1989;84:1017–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Blackstone MM, Mittal MK. The edematous toddler: a case of pediatric Menetrier disease. Pediatr Emerg Care. 2008;24:682–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Celikel C, Eren F, Gulluoglu B, et al. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res. 2007;13:215–26.PubMedCrossRefGoogle Scholar
  5. 5.
    Coffey RJ, Washington MK, Corless CL, Heinrich MC. Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Crampton JR, Hunter JO, Neale G, Wight DG. Chronic lymphocytic gastritis and protein losing gastropathy. Gut. 1989;30 Spec No:71-74.Google Scholar
  7. 7.
    • Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–63. This landmark paper represents the start of a new era in the pathophysiology of MD indicating for the first time the link between gastric mucosal TGFα overexpression with increased EGFR signaling and hyperplastic foveolar epithelium in patients with MD. PubMedGoogle Scholar
  8. 8.
    Elinav E, Korem M, Ofran Y, et al. Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus. Lupus. 2004;13:60–3.PubMedCrossRefGoogle Scholar
  9. 9.
    • Fiske WH, Tanksley J, Nam KT, et al. Efficacy of cetuximab in the treatment of Menetrier’s disease. Sci Transl. Med 2009;1:8ra18. This paper reports promising data of the first trial of treatment with a high-affinity EGF receptor blocking antibody(cetuximab) indicating the use of this novel biological agent as first-line therapy in severe protein-losing MD.PubMedCrossRefGoogle Scholar
  10. 10.
    Friedman J, Platnick J, Farruggia S, et al. Menetrier disease. Radiographics. 2009;29:297–301.PubMedCrossRefGoogle Scholar
  11. 11.
    Goebel M, Stengel A, Lambrecht NW, Sachs G. Selective gene expression by rat gastric corpus epithelium. Physiol Genomics. 43:237–54Google Scholar
  12. 12.
    Hsu CT, Ito M, Kawase Y, et al. Early gastric cancer arising from localized Menetrier’s disease. Gastroenterol Jpn. 1991;26:213–7.PubMedGoogle Scholar
  13. 13.
    Kim J, Cheong JH, Chen J, et al. Menetrier’s disease in korea: report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J. 2004;45:555–60.PubMedGoogle Scholar
  14. 14.
    Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Menetrier’s disease associated with cytomegalovirus. Pediatr Infect Dis J. 1993;12:1011–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Lam SK, Hui WK, Ho J, et al. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology. 1983;84:834–9.PubMedGoogle Scholar
  16. 16.
    Larsen B, Tarp U, Kristensen E. Familial giant hypertrophic gastritis (Menetrier’s disease). Gut. 1987;28:1517–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Lechago J, Genta RM. Stomach and duodenum. In: Damjanov I, Linder J, editors. Anderson’s pathology. New York: Mosby; 1996. 1684.Google Scholar
  18. 18.
    Lewis JJ, Goldenring JR, Modlin IM, Coffey RJ. Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism. Surgery. 1990;108:220–6. discussion 226–227.PubMedGoogle Scholar
  19. 19.
    Maffei M, Piessevaux H, Jouret-Mourin A. Polypoid lesions in the stomach and proximal esophagus. Menetrier’s disease of the stomach. Gastroenterology. 140:32, 369.Google Scholar
  20. 20.
    Ménétrier P. Des polyadenomes gastriques et leur rapport avec le cancer de l’estomac. Arch Physiol Norm Pathol. 1888;1:236–62.Google Scholar
  21. 21.
    Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl. 1992;194:1–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Meyer J. Polyposis gastrica (Polyadenomata). JAMA. 1960;1913:61.Google Scholar
  23. 23.
    Moon SY, Kim KO, Park SH, et al. [Gastritis cystica profunda accompanied by multiple early gastric cancers]. Korean J Gastroenterol. 55:325–30.Google Scholar
  24. 24.
    Nguyen VX, Nguyen CC, Leighton JA, et al. The association of Menetrier disease with ulcerative colitis: a case report with implications on the pathogenesis of Menetrier disease. Case Rep Gastroenterol. 4:66–70.Google Scholar
  25. 25.
    Oguri A, Ohmiya N, Taguchi A, et al. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes. Eur J Gastroenterol Hepatol. 2007;19:561–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Ohyama I, Ohmiya N, Niwa Y, et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:693–700.PubMedCrossRefGoogle Scholar
  27. 27.
    Rhodes JA, Tam JP, Finke U, et al. Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A. 1986;83:3844–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Rich A, Toro TZ, Tanksley J, et al. Distinguishing Menetrier’s disease from its mimics. Gut. 2010;59:1617–24.PubMedCrossRefGoogle Scholar
  29. 29.
    Romano M, Polk WH, Awad JA, et al. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest. 1992;90:2409–21.PubMedCrossRefGoogle Scholar
  30. 30.
    Saadia B, Salna BH, Mohamed J, et al. Menetrier’s disease and gastric carcinoma. Tunis Med. 2005;83:499–502.PubMedGoogle Scholar
  31. 31.
    Scharschmidt BF. The natural history of hypertrophic gastrophy (Menetrier’s disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med. 1977;63:644–52.PubMedCrossRefGoogle Scholar
  32. 32.
    earcy RM, Malagelada JR. Menetrier’s disease and idiopathic hypertrophic gastropathy. Ann Intern Med. 1984;100:565–70.PubMedGoogle Scholar
  33. 33.
    Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992;90:1161–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Tsuji T, Iwahashi M, Nakamori M, et al. Multiple early gastric cancer with gastritis cystica profunda showing various histological types. Hepatogastroenterology. 2008;55:1150–2.PubMedGoogle Scholar
  35. 35.
    Turner JR, Odze RD. Polyps of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. New York: Saunders; 2004. p. 274–5.Google Scholar
  36. 36.
    Wood MG, Bates C, Brown RC, Losowsky MS. Intramucosal carcinoma of the gastric antrum complicating Menetrier’s disease. J Clin Pathol. 1983;36:1071–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC (outside the USA) 2011

Authors and Affiliations

  1. 1.Gastrointestinal EndocrinologyLong Beach VA Medical CenterLong BeachUSA

Personalised recommendations